RIPE-KG · Version 1.1.0 · Resource

ripekg:evidence-aggregation/RIPEA44677276976C010D

https://w3id.org/ripe/ripe-kg/evidence-aggregation/RIPEA44677276976C010D
SubjectPredicateObject
ripekg:evaluation/RIPEA44677276976C010D prov:wasInformedBy ripekg:evidence-aggregation/RIPEA44677276976C010D
ripekg:evidence-aggregation/RIPEA44677276976C010D rdf:type rdfs:Resource
ripekg:evidence-aggregation/RIPEA44677276976C010D rdf:type owl:Thing
ripekg:evidence-aggregation/RIPEA44677276976C010D rdf:type ripe:EvidenceAggregationEvidence aggregation
ripekg:evidence-aggregation/RIPEA44677276976C010D rdf:type tido:Activity
ripekg:evidence-aggregation/RIPEA44677276976C010D prov:startedAtTime 2026-02-18T16:42:29.942889Z
ripekg:evidence-aggregation/RIPEA44677276976C010D prov:wasAssociatedWith ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0
ripekg:evidence-aggregation/RIPEA44677276976C010D prov:wasAssociatedWith ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI
ripekg:evidence-aggregation/RIPEA44677276976C010D tido:contributesTo ripekg:research-integrity-assessment/RIPEA44677276976C010D
ripekg:publication-details/RIPEA44677276976C010DPrevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA44677276976C010D
ripekg:registry-evidence/RIPEA44677276976C010D prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA44677276976C010D
ripekg:study-design-evidence/RIPEA44677276976C010D prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA44677276976C010D